Suchergebnisse

PubPharm (3.773)

1

Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant

enthalten in: The Cochrane database of systematic reviews | 2024

von Langer, P. | John, L. | Monsef, I. | +3

2

Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US

enthalten in: JAMA network open | 2024

von Mathew Thomas, V. | Jo, Y. | Tripathi, N. | +13

3

Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance

enthalten in: Nature cancer | 2024

von Zheng, H. | Liu, J. | Cheng, Q. | +19

4

A nanomedicine composed of polymer-ss-DOX and polymer-Ce6 prodrugs with monoclonal antibody targeting effect for anti-tumor chemo-photodynamic synergetic therapy

enthalten in: Acta biomaterialia | 2024

von Yu, L. | Zhang, M. | He, J. | +2

5

Clinical Pharmacology of the Antibody-Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors

enthalten in: Clinical pharmacokinetics | 2024

von Tang, M. | Garg, A. | Bonate, P. | +14

6

Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model

enthalten in: Clinical & experimental metastasis | 2024

von Pourjamal, N. | Yazdi, N. | Halme, A. | +5

7

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells

enthalten in: Cancer biology & therapy | 2024

von Wang, H. | Koob, T. | Fromm, J. | +3

8

Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors

enthalten in: Clinical and translational science | 2024

von Robbrecht, D. | Grob, J. | Bechter, O. | +20

9

Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes : resetting synergistic activity

enthalten in: Blood cancer journal | 2024

von Kostopoulos, I. | Fotiou, D. | Gavriatopoulou, M. | +14

10

Investigation of Immunogenicity Assessment of Biosimilar Monoclonal Antibodies in the United States

enthalten in: Clinical pharmacology and therapeutics | 2023

von Cheng, C. | Jiang, A. | Liu, Y. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[378]